PGE(2)/EP4 receptor attenuated mucosal injury via beta-arrestin1/Src/EGFR-mediated proliferation in portal hypertensive gastropathy
PGE(2)/EP4 receptor attenuated mucosal injury via beta-arrestin1/Src/EGFR-mediated proliferation in portal hypertensive gastropathy
复制标题
PGE(2)/EP4受体通过β-arrestin1/Src/EGFR介导的增殖减轻门静脉高压性胃病的粘膜损伤
DOI:
10.1111/bph.13752
复制
发表时间:
2017
影响因子:
7.3
通讯作者:
Wu Bin
中科院分区:
文献类型:
--
作者:
Tan Siwei;Chen Xiaoliang;Xu Minyi;Huang Xiaoli;Liu Huiling;Jiang Jie;Lu Yu;Peng Xiaojie;Wu Bin
Background and PurposePortal hypertensive gastropathy (PHG) is a serious complication of liver cirrhosis and a potential cause of bleeding in patients with cirrhosis. Suppressed mucosal epithelial proliferation is a crucial pathological characteristic of PHG. Our studies demonstrated an important role for PGE2and its EP4receptor in the promotion of mucosal proliferation. However, whether β‐arrestin1 (β‐arr1), a well‐established mediator of GPCRs, is involved in the PGE2/EP4receptor‐mediated mucosal proliferation complex in PHG remains unclear. The aim of the study was to investigate whether β‐arr1 participated in PGE2/EP4receptor‐mediated mucosal proliferation by recruiting the Src/EGF receptor (EGFR) complex to activate Akt/proliferating cell nuclear antigen (PCNA) signalling in PHG.Experimental ApproachGastric mucosal proliferation was examined in patients with PHG and the PHG model ofβ‐arr1‐knockout (β‐arr1‐KO) andβ‐arr1‐wild type (β‐arr1‐WT) mice. The induction of β‐arr1 and EP4receptor expression and the Src/EGFR signalling elements was investigated, and the mechanisms underlying PGE2‐regulated gastric mucosal proliferation were analysed.Key ResultsPortal hypertension suppressed COX‐1 but not COX‐2, which was accompanied by a down‐regulation of PGE2generation and EP4receptor levels in the mucosa of patients with PHG. PGE2administration markedly promoted mucosal proliferation in a mouse model of PHG. Targeted deletion ofβ‐arr1abolished PGE2/EP4receptor‐mediated gastric proliferation in PHG by repressing the Src/EGFR/Akt/PCNA signalling network.Conclusions and ImplicationsThese results indicate that β‐arr1 regulates PGE2/EP4receptor‐mediated mucosal proliferation by promoting activation of the Src/EGFR/Akt/PCNA signalling pathway, and thus, this network is a potential therapeutic target for PHG.